Seema Kumar1, Eileen C King2, Amy L Christison3, Aaron S Kelly4, Adolfo J Ariza5, Claudia Borzutzky6, Suzanne Cuda7, Shelley Kirk8. 1. Division of Pediatric Endocrinology and Metabolism, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN. 2. Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH. 3. Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, IL. 4. Department of Pediatrics, Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, MN. 5. Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL. 6. Department of Pediatrics, Keck School of Medicine of USC, Los Angeles, CA; Diabetes and Obesity Program, Children's Hospital Los Angeles, Los Angeles, CA. 7. Department of Pediatrics, Pediatric Weight Management, Children's Hospital of San Antonio, Baylor College of Medicine, Houston, TX. 8. Department of Pediatrics, University of Cincinnati, College of Medicine, Cincinnati, OH; The Heart Institute, Center for Better Health and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Electronic address: Shelley.Kirk@cchmc.org.
Abstract
OBJECTIVE: To describe treatment outcomes of children and adolescents enrolled in the Pediatric Obesity Weight Evaluation Registry, a consortium of multicomponent pediatric weight management programs in the US. STUDY DESIGN: This multicenter prospective observational cohort study, established in 2013, includes youth (2-18 years of age) with obesity enrolled from 31 Pediatric Obesity Weight Evaluation Registry (POWER) sites over a 2-year period and followed up to 12 months. Weight status was evaluated by the percentage of the 95th percentile for body mass index (%BMIp95). Associations of weight status outcomes with patient characteristics and program exposure were analyzed with multivariable mixed effects modeling. RESULTS: We included 6454 children and adolescents (median age, 11 years; IQR, 9-14 years; 53% white, 32% Hispanic; 73% with severe obesity) who were enrolled in POWER. Median changes in %BMIp95 for this cohort were -1.88 (IQR, -5.8 to 1.4), -2.50 (IQR, -7.4 to 1.8), -2.86 (IQR, -8.7 to 1.9), at 4-6, 7-9, and 10-12 of months follow-up, respectively (all P < .05). Older age (≥12 years), greater severity of obesity, and Hispanic race/ethnicity were associated with better improvement in %BMIp95. A 5-percentage point decrease in %BMIp95 was associated with improvement in cardiometabolic risk factors. CONCLUSIONS: Overall, treatment in pediatric weight management programs is associated with a modest median decrease in BMI as measured by change in %BMIp95. Further studies are needed to confirm these findings, as well as to identify additional strategies to enhance the effectiveness of these multicomponent interventions for youth with severe obesity. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02121132.
OBJECTIVE: To describe treatment outcomes of children and adolescents enrolled in the Pediatric Obesity Weight Evaluation Registry, a consortium of multicomponent pediatric weight management programs in the US. STUDY DESIGN: This multicenter prospective observational cohort study, established in 2013, includes youth (2-18 years of age) with obesity enrolled from 31 Pediatric Obesity Weight Evaluation Registry (POWER) sites over a 2-year period and followed up to 12 months. Weight status was evaluated by the percentage of the 95th percentile for body mass index (%BMIp95). Associations of weight status outcomes with patient characteristics and program exposure were analyzed with multivariable mixed effects modeling. RESULTS: We included 6454 children and adolescents (median age, 11 years; IQR, 9-14 years; 53% white, 32% Hispanic; 73% with severe obesity) who were enrolled in POWER. Median changes in %BMIp95 for this cohort were -1.88 (IQR, -5.8 to 1.4), -2.50 (IQR, -7.4 to 1.8), -2.86 (IQR, -8.7 to 1.9), at 4-6, 7-9, and 10-12 of months follow-up, respectively (all P < .05). Older age (≥12 years), greater severity of obesity, and Hispanic race/ethnicity were associated with better improvement in %BMIp95. A 5-percentage point decrease in %BMIp95 was associated with improvement in cardiometabolic risk factors. CONCLUSIONS: Overall, treatment in pediatric weight management programs is associated with a modest median decrease in BMI as measured by change in %BMIp95. Further studies are needed to confirm these findings, as well as to identify additional strategies to enhance the effectiveness of these multicomponent interventions for youth with severe obesity. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02121132.
Authors: Taylor S Lane; Derek L Sonderegger; Whitney M Holeva-Eklund; Keith Brazendale; Timothy K Behrens; Hiliary Howdeshell; Sherry Walka; Jon R Cook; Hendrik D de Heer Journal: Am J Prev Med Date: 2021-02-23 Impact factor: 5.043
Authors: Patrick G McPhee; Ian Zenlea; Jill K Hamilton; Josephine Ho; Geoff D C Ball; Rajibul Mian; Annick Buchholz; Anne-Marie Laberge; Laurent Legault; Mark S Tremblay; Jean-Pierre Chanoine; Lehana Thabane; Katherine M Morrison Journal: Int J Obes (Lond) Date: 2021-09-09 Impact factor: 5.095
Authors: Karen E Schaller; Linda J Stephenson-Somers; Adolfo J Ariza; Maheen Quadri; Helen J Binns Journal: Int J Environ Res Public Health Date: 2019-03-14 Impact factor: 3.390
Authors: Ihuoma Eneli; Jinyu Xu; Alexis Tindall; Rosanna Watowicz; Jennifer Worthington; Kelly Tanner; Keeley Pratt; Marnie Walston Journal: Int J Environ Res Public Health Date: 2019-08-23 Impact factor: 3.390
Authors: Ellen A Schur; Susan J Melhorn; Kelley Scholz; Mary Rosalynn B De Leon; Clinton T Elfers; Maya G Rowland; Brian E Saelens; Christian L Roth Journal: Int J Obes (Lond) Date: 2020-07-26 Impact factor: 5.095